Open original FDA record ↗Recall record
- FDA identifier
- Z-1265-2016
- Company in FDA record
- Biomet, Inc.
- FDA classification date
- Mar 25, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The anterior/posterior (AP) dimension may be oversized by 0.016. If the femoral component does not fit as tightly as intended, bony ingrowth may not occur causing loosening of the femoral component. A revision surgery may be necessary.
Source facts
- Action
- On 2/5/2016, URGENT MEDICAL DEVICE RECALL NOTICE notifications were sent to the affected distributors, hospital risk managers, and implanting surgeons via courier. Distributors were instructed to locate and return the affected product, hospitals to locate and discontinue use, and implanting surgeons to monitor patients. The recall notification included a description of the reason for the recall, affected product, consignee responsibilities, and instructions for responding to the formal recall notification. Questions related to this notice should be directed to (574) 372-1570, Monday through Friday, 8 a.m. to 5 p.m.
- Initiated
- 2016-02-05
- Root cause
- Device Design
- Terminated
- 2017-03-28
- Distribution
- UT Netherlands
- Recall number
- Z-1265-2016
- Recall status
- Terminated
- CDRH record ID
- 144063
- FDA classified
- 2016-03-25
- Recall event number
- 73400